A carregar...

Cladribine with immediate rituximab for the treatment of patients with variant hairy cell leukemia

PURPOSE: In contrast to the classic form, variant hairy cell leukemia (HCLv) responds poorly to single-agent purine analogs, expresses unmutated BRAF, has shorter overall survival, and lacks effective standard therapy. No treatment has achieved a high complete remission rate even in small series, an...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kreitman, Robert J., Wilson, Wyndham, Calvo, Katherine R., Arons, Evgeny, Roth, Laura, Sapolsky, Jeffrey, Zhou, Hong, Raffeld, Mark, Stetler-Stevenson, Maryalice
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3867590/
https://ncbi.nlm.nih.gov/pubmed/24277451
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-13-1752
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!